Literature DB >> 12369203

Genetically modified Streptococcus mutans for the prevention of dental caries.

Jeffrey D Hillman1.   

Abstract

There are many examples of positive and negative interactions between different species of bacteria inhabiting the same ecosystem. This observation provides the basis for a novel approach to preventing microbial diseases called replacement therapy. In this approach, a harmless effector strain is permanently implanted in the host's microflora. Once established, the presence of the effector strain prevents the colonization or outgrowth of a particular pathogen. In the case of dental caries, replacement therapy has involved construction of an effector strain called BCS3-L1, which was derived from a clinical Streptococcus mutans isolate. Recombinant DNA technology was used to delete the gene encoding lactate dehydrogenase in BCS3-L1 making it entirely deficient in lactic acid production. This effector strain was also designed to produce elevated amounts of a novel peptide antibiotic called mutacin 1140 that gives it a strong selective advantage over most other strains of S. mutans. In laboratory and rodent model studies, BCS3-L1 was found to be genetically stable and to produce no apparent deleterious side effects during prolonged colonization. BCS3-L1 was significantly less cariogenic than wild-type S. mutans in gnotobiotic rats, and it did not contribute at all to the cariogenic potential of the indigenous flora of conventional Sprague-Dawley rats. And, its strong colonization properties indicated that a single application of the BCS3-L1 effector strain to human subjects should result in its permanent implantation and displacement over time of indigenous, disease-causing S. mutans strains. Thus, BCS3-L1 replacement therapy for the prevention of dental caries is an example of biofilm engineering that offers the potential for a highly efficient, cost effective augmentation of conventional prevention strategies. It is hoped that the eventual success of replacement therapy for the prevention of dental caries will stimulate the use of this approach in the prevention of other bacterial diseases.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12369203

Source DB:  PubMed          Journal:  Antonie Van Leeuwenhoek        ISSN: 0003-6072            Impact factor:   2.271


  30 in total

Review 1.  Bacteriocin production: a probiotic trait?

Authors:  Alleson Dobson; Paul D Cotter; R Paul Ross; Colin Hill
Journal:  Appl Environ Microbiol       Date:  2011-10-28       Impact factor: 4.792

2.  Functional foods/ingredients and dental caries.

Authors:  Cor van Loveren; Zdenek Broukal; Edgar Oganessian
Journal:  Eur J Nutr       Date:  2012-07       Impact factor: 5.614

3.  A Review of Probiotic Therapy in Preventive Dental Practice.

Authors:  Mark L Cannon
Journal:  Probiotics Antimicrob Proteins       Date:  2011-06       Impact factor: 4.609

4.  Community health care: therapeutic opportunities in the human microbiome.

Authors:  Justin L Sonnenburg; Michael A Fischbach
Journal:  Sci Transl Med       Date:  2011-04-13       Impact factor: 17.956

Review 5.  Interspecies interactions within oral microbial communities.

Authors:  Howard K Kuramitsu; Xuesong He; Renate Lux; Maxwell H Anderson; Wenyuan Shi
Journal:  Microbiol Mol Biol Rev       Date:  2007-12       Impact factor: 11.056

6.  Assessment of gut bacteria for a paratransgenic approach to control Dermolepida albohirtum larvae.

Authors:  Geoffrey W Pittman; Stevens M Brumbley; Peter G Allsopp; Scott L O'Neill
Journal:  Appl Environ Microbiol       Date:  2008-05-02       Impact factor: 4.792

7.  Carboxyl Analogue of Mutacin 1140, a Scaffold for Lead Antibacterial Discovery.

Authors:  Jerome Escano; Akshaya Ravichandran; Bita Salamat; Leif Smith
Journal:  Appl Environ Microbiol       Date:  2017-06-30       Impact factor: 4.792

Review 8.  Bacteriocins - a viable alternative to antibiotics?

Authors:  Paul D Cotter; R Paul Ross; Colin Hill
Journal:  Nat Rev Microbiol       Date:  2012-12-24       Impact factor: 60.633

Review 9.  The dual role of bacteriocins as anti- and probiotics.

Authors:  O Gillor; A Etzion; M A Riley
Journal:  Appl Microbiol Biotechnol       Date:  2008-10-14       Impact factor: 4.813

Review 10.  Using bacterial genomes and essential genes for the development of new antibiotics.

Authors:  Francisco R Fields; Shaun W Lee; Michael J McConnell
Journal:  Biochem Pharmacol       Date:  2016-12-08       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.